These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19671749)

  • 41. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor.
    Kleinau G; Heyder NA; Tao YX; Scheerer P
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Melanocortin 4 receptor activates ERK-cFos pathway to increase brain-derived neurotrophic factor expression in rat astrocytes and hypothalamus.
    Ramírez D; Saba J; Carniglia L; Durand D; Lasaga M; Caruso C
    Mol Cell Endocrinol; 2015 Aug; 411():28-37. PubMed ID: 25892444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands.
    Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Common requirements for melanocortin-4 receptor selectivity of structurally unrelated melanocortin agonist and endogenous antagonist, Agouti protein.
    Oosterom J; Garner KM; den Dekker WK ; Nijenhuis WA; Gispen WH; Burbach JP; Barsh GS; Adan RA
    J Biol Chem; 2001 Jan; 276(2):931-6. PubMed ID: 11024027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Minimization of MC1R selectivity by modification of the core structure of alpha-MSH-ND.
    Lim S; Li S; Lee C; Yoon C; Baik J; Lee W
    Chem Biol; 2001 Sep; 8(9):857-70. PubMed ID: 11564554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. D-Amino acid scan of gamma-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity.
    Grieco P; Balse PM; Weinberg D; MacNeil T; Hruby VJ
    J Med Chem; 2000 Dec; 43(26):4998-5002. PubMed ID: 11150170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Delta-Opioid Receptor (δOR) Targeted Near-Infrared Fluorescent Agent for Imaging of Lung Cancer: Synthesis and Evaluation In Vitro and In Vivo.
    Cohen AS; Patek R; Enkemann SA; Johnson JO; Chen T; Toloza E; Vagner J; Morse DL
    Bioconjug Chem; 2016 Feb; 27(2):427-38. PubMed ID: 26488422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular characterization of feline melanocortin 4 receptor and melanocortin 2 receptor accessory protein 2.
    Habara M; Mori N; Okada Y; Kawasumi K; Nakao N; Tanaka Y; Arai T; Yamamoto I
    Gen Comp Endocrinol; 2018 May; 261():31-39. PubMed ID: 29360464
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of a nonpeptidic ligand for imaging of cholecystokinin 2 receptor-expressing cancers.
    Wayua C; Low PS
    J Nucl Med; 2015 Jan; 56(1):113-9. PubMed ID: 25500824
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluorescence anisotropy assay for pharmacological characterization of ligand binding dynamics to melanocortin 4 receptors.
    Veiksina S; Kopanchuk S; Rinken A
    Anal Biochem; 2010 Jul; 402(1):32-9. PubMed ID: 20302839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells.
    Selkirk JV; Nottebaum LM; Lee J; Yang W; Foster AC; Lechner SM
    Neuropharmacology; 2007 Feb; 52(2):459-66. PubMed ID: 17095023
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structure and function of the potent cyclic and linear melanocortin analogues.
    Cho MK; Lee CJ; Lee CH; Li SZ; Lim SK; Baik JH; Lee W
    J Struct Biol; 2005 Jun; 150(3):300-8. PubMed ID: 15890278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and biological studies of efficient multivalent melanotropin ligands: tools toward melanoma diagnosis and treatment.
    Brabez N; Lynch RM; Xu L; Gillies RJ; Chassaing G; Lavielle S; Hruby VJ
    J Med Chem; 2011 Oct; 54(20):7375-84. PubMed ID: 21928837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and characterization of a Eu-DTPA-PEGO-MSH(4) derivative for evaluation of binding of multivalent molecules to melanocortin receptors.
    Xu L; Vagner J; Alleti R; Rao V; Jagadish B; Morse DL; Hruby VJ; Gillies RJ; Mash EA
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2489-92. PubMed ID: 20304640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of ligand binding to melanocortin 4 receptors using fluorescent peptides with improved kinetic properties.
    Link R; Veiksina S; Rinken A; Kopanchuk S
    Eur J Pharmacol; 2017 Mar; 799():58-66. PubMed ID: 28132916
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of pH, salt and time on ligand binding properties of overexpressed melanocortin 4 receptor.
    Dolby V; Lundqvist A; Fröberg T; Lüllau E; Shaw J; Tjerneld F; Cronet P
    J Biochem Biophys Methods; 2004 Mar; 58(3):195-205. PubMed ID: 15026206
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Agouti-related protein (83-132) is a competitive antagonist at the human melanocortin-4 receptor: no evidence for differential interactions with pro-opiomelanocortin-derived ligands.
    Pritchard LE; Armstrong D; Davies N; Oliver RL; Schmitz CA; Brennand JC; Wilkinson GF; White A
    J Endocrinol; 2004 Jan; 180(1):183-91. PubMed ID: 14709157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potent and selective agonists of human melanocortin receptor 5: cyclic analogues of alpha-melanocyte-stimulating hormone.
    Bednarek MA; MacNeil T; Tang R; Fong TM; Cabello MA; Maroto M; Teran A
    J Med Chem; 2007 May; 50(10):2520-6. PubMed ID: 17455928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rigid linkers for bioactive peptides.
    Vagner J; Handl HL; Monguchi Y; Jana U; Begay LJ; Mash EA; Hruby VJ; Gillies RJ
    Bioconjug Chem; 2006; 17(6):1545-50. PubMed ID: 17105235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.